Loading...

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

PURPOSE: Peptide antigens have been administered by different approaches as cancer vaccine therapy, including direct injection or pulsed onto dendritic cells; however, the optimal delivery method is still debatable. In this study, we describe the immune response elicited by two vaccine approaches us...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Rahma, Osama E., Ashtar, Ed, Czystowska, Malgorzata, Szajnik, Marta E., Wieckowski, Eva, Bernstein, Sarah, Herrin, Vincent E., Shams, Mortada A., Steinberg, Seth M., Merino, Maria, Gooding, William, Visus, Carmen, DeLeo, Albert B., Wolf, Judith K., Bell, Jeffrey G., Berzofsky, Jay A., Whiteside, Theresa L., Khleif, Samir N.
Format: Artigo
Sprog:Inglês
Udgivet: Springer-Verlag 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708463/
https://ncbi.nlm.nih.gov/pubmed/21927947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-011-1100-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!